Alexander Ploss, Ph.D. - Publications

2005 Weill Cornell Medical College, New York, NY, United States 
Immunology, Microbiology Biology

104 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Nimgaonkar I, Archer NF, Becher I, Shahrad M, LeDesma R, Mateus A, Caballero-Gómez J, Berneshawi AR, Ding Q, Douam F, Gaska JM, Savitski MM, Kim H, Ploss A. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90. Antiviral Research. 104997. PMID 33326835 DOI: 10.1016/j.antiviral.2020.104997  1
2020 Ramanathan HN, Zhang S, Douam F, Mar KB, Chang J, Yang PL, Schoggins JW, Ploss A, Lindenbach BD. A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating. Mbio. 11. PMID 32291299 DOI: 10.1128/mBio.00467-20  1
2020 Chen CY, Winer BY, Chavez D, Guerra B, Brasky KM, Eng S, Salas E, Tam D, Simmons JH, Abee CR, Delaney WE, Ploss A, Lanford RE, Voitenleitner C. Woolly Monkey-HBV Infection in Squirrel Monkeys as a Surrogate Nonhuman Primate Model of HBV Infection. Hepatology Communications. 4: 371-386. PMID 32140655 DOI: 10.1002/hep4.1471  1
2019 Gaska JM, Parsons L, Balev M, Cirincione A, Wang W, Schwartz RE, Ploss A. Conservation of cell-intrinsic immune responses in diverse nonhuman primate species. Life Science Alliance. 2. PMID 31649152 DOI: 10.26508/lsa.201900495  1
2019 Winer BY, Gaska JM, Lipkowitz G, Bram Y, Parekh A, Parsons L, Leach R, Jindal R, Cho CH, Shrirao A, Novik E, Schwartz RE, Ploss A. Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system. Hepatology (Baltimore, Md.). PMID 31206195 DOI: 10.1002/hep.30815  1
2019 Gaska JM, Balev M, Ding Q, Heller B, Ploss A. Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus. Elife. 8. PMID 31074414 DOI: 10.7554/eLife.44436  1
2019 Gaska JM, Ding Q, Ploss A. Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies. Methods in Molecular Biology (Clifton, N.J.). 1911: 481-503. PMID 30593647 DOI: 10.1007/978-1-4939-8976-8_33  1
2018 Douam F, Ziegler CGK, Hrebikova G, Fant B, Leach R, Parsons L, Wang W, Gaska JM, Winer BY, Heller B, Shalek AK, Ploss A. Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses. Nature Communications. 9: 5031. PMID 30487575 DOI: 10.1038/s41467-018-07478-2  1
2018 Winer BY, Shirvani-Dastgerdi E, Bram Y, Sellau J, Low BE, Johnson H, Huang T, Hrebikova G, Heller B, Sharon Y, Giersch K, Gerges S, Seneca K, Pais MA, Frankel AS, ... ... Ploss A, et al. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Science Translational Medicine. 10. PMID 29950446 DOI: 10.1126/scitranslmed.aap9328  1
2018 Douam F, Ploss A. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe. Trends in Microbiology. PMID 29933925 DOI: 10.1016/j.tim.2018.05.012  1
2018 Ding Q, Gaska JM, Douam F, Wei L, Kim D, Balev M, Heller B, Ploss A. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease. Proceedings of the National Academy of Sciences of the United States of America. PMID 29915078 DOI: 10.1073/pnas.1803406115  1
2018 Ding Q, Nimgaonkar I, Archer NF, Bram Y, Heller B, Schwartz RE, Ploss A. Identification of the Intragenomic Promoter Controlling Hepatitis E Virus Subgenomic RNA Transcription. Mbio. 9. PMID 29739903 DOI: 10.1128/mBio.00769-18  1
2018 Dragovic SM, Agunbiade TA, Freudzon M, Yang J, Hastings AK, Schleicher TR, Zhou X, Craft S, Chuang YM, Gonzalez F, Li Y, Hrebikova G, Tripathi A, Mlambo G, Almeras L, ... Ploss A, et al. Immunization with AgTRIO, a Protein in Anopheles Saliva, Contributes to Protection against Plasmodium Infection in Mice. Cell Host & Microbe. 23: 523-535.e5. PMID 29649443 DOI: 10.1016/j.chom.2018.03.008  1
2018 Douam F, Ploss A. The use of humanized mice for studies of viral pathogenesis and immunity. Current Opinion in Virology. 29: 62-71. PMID 29604551 DOI: 10.1016/j.coviro.2018.03.003  1
2018 Douam F, Fusil F, Enguehard M, Dib L, Nadalin F, Schwaller L, Hrebikova G, Mancip J, Mailly L, Montserret R, Ding Q, Maisse C, Carlot E, Xu K, Verhoeyen E, ... ... Ploss A, et al. A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. Plos Pathogens. 14: e1006908. PMID 29505618 DOI: 10.1371/journal.ppat.1006908  1
2017 Nimgaonkar I, Ding Q, Schwartz RE, Ploss A. Hepatitis E virus: advances and challenges. Nature Reviews. Gastroenterology & Hepatology. PMID 29162935 DOI: 10.1038/nrgastro.2017.150  1
2017 Douam F, Soto Albrecht YE, Hrebikova G, Sadimin E, Davidson C, Kotenko SV, Ploss A. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo. Mbio. 8. PMID 28811340 DOI: 10.1128/mBio.00819-17  1
2017 Winer BY, Huang TS, Pludwinski E, Heller B, Wojcik F, Lipkowitz GE, Parekh A, Cho C, Shrirao A, Muir TW, Novik E, Ploss A. Long-term hepatitis B infection in a scalable hepatic co-culture system. Nature Communications. 8: 125. PMID 28743900 DOI: 10.1038/s41467-017-00200-8  1
2017 Li D, Wang X, von Schaewen M, Tao W, Zhang Y, Heller B, Hrebikova G, Deng Q, Sun Q, Ploss A, Zhong J, Huang Z. Immunization with a subunit hepatitis C virus vaccine elicits pan-genotypic neutralizing antibodies and intra-hepatic T-cell responses in non-human primates. The Journal of Infectious Diseases. PMID 28398489 DOI: 10.1093/infdis/jix180  1
2017 Shirvani-Dastgerdi E, Winer BY, Celia-Terrassa A, Kang Y, Tabernero D, Yagmur E, Rodríguez-Frías F, Gregori J, Luedde T, Trautwein C, Ploss A, Tacke F. Selection of the highly replicative and partially multidrug resistant rtS78T polymerase mutation in two patients with chronic hepatitis B virus infection during tenofovir-entecavir combination therapy. Journal of Hepatology. PMID 28392234 DOI: 10.1016/j.jhep.2017.03.027  1
2017 Douam F, Hrebikova G, Albrecht YE, Sellau J, Sharon Y, Ding Q, Ploss A. Single-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcome. Nature Communications. 8: 14781. PMID 28290449 DOI: 10.1038/ncomms14781  1
2017 Ding Q, Heller B, Capuccino JM, Song B, Nimgaonkar I, Hrebikova G, Contreras JE, Ploss A. Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proceedings of the National Academy of Sciences of the United States of America. PMID 28096411 DOI: 10.1073/pnas.1614955114  1
2016 Winer BY, Huang T, Low BE, Avery C, Pais MA, Hrebikova G, Siu E, Chiriboga L, Wiles MV, Ploss A. Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection. Virology. 502: 63-72. PMID 28006671 DOI: 10.1016/j.virol.2016.12.017  1
2016 Ding Q, von Schaewen M, Hrebikova G, Heller B, Sandmann L, Plaas M, Ploss A. Mice expressing minimally humanized CD81 and occludin genes support hepatitis C virus uptake in vivo. Journal of Virology. PMID 27928007 DOI: 10.1128/JVI.01799-16  1
2016 von Schaewen M, Dorner M, Hueging K, Foquet L, Gerges S, Hrebikova G, Heller B, Bitzegeio J, Doerrbecker J, Horwitz JA, Gerold G, Suerbaum S, Rice CM, Meuleman P, Pietschmann T, ... Ploss A, et al. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation. Mbio. 7. PMID 27834208 DOI: 10.1128/mBio.01915-16  1
2016 Li D, von Schaewen M, Wang X, Tao W, Zhang Y, Li L, Heller B, Hrebikova G, Deng Q, Ploss A, Zhong J, Huang Z. Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice. Journal of Virology. PMID 27630242 DOI: 10.1128/JVI.01462-16  1
2016 Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology. 20: 1-10. PMID 27504999 DOI: 10.1016/j.coviro.2016.07.009  1
2016 Basta NE, Mahmoud AA, Wolfson J, Ploss A, Heller BL, Hanna S, Johnsen P, Izzo R, Grenfell BT, Findlow J, Bai X, Borrow R. Immunogenicity of a Meningococcal B Vaccine during a University Outbreak. The New England Journal of Medicine. 375: 220-228. PMID 27468058 DOI: 10.1056/NEJMoa1514866  1
2016 von Schaewen M, Hrebikova G, Ploss A. Generation of Human Liver Chimeric Mice for the Study of Human Hepatotropic Pathogens. Methods in Molecular Biology (Clifton, N.J.). 1438: 79-101. PMID 27150085 DOI: 10.1007/978-1-4939-3661-8_5  1
2016 Winer BY, Ding Q, Gaska J, Ploss A. In vivo models of hepatitis B and C virus infection. Febs Letters. PMID 27009462 DOI: 10.1002/1873-3468.12157  1
2016 Douam F, Ding Q, Ploss A. Recent advances in understanding hepatitis C. F1000research. 5. PMID 26918166 DOI: 10.12688/f1000research.7354.1  1
2016 Winer BY, Ploss A. Breaking the species barrier for hepatitis delta virus. Hepatology (Baltimore, Md.). 63: 334-6. PMID 26289017 DOI: 10.1002/hep.28129  1
2015 von Schaewen M, Ploss A. Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy. Cellular and Molecular Gastroenterology and Hepatology. 1: 257-258. PMID 28210676 DOI: 10.1016/j.jcmgh.2015.03.005  1
2015 Douam F, Gaska JM, Winer BY, Ding Q, von Schaewen M, Ploss A. Genetic Dissection of the Host Tropism of Human-Tropic Pathogens. Annual Review of Genetics. PMID 26407032 DOI: 10.1146/annurev-genet-112414-054823  1
2015 Perin PM, Haid S, Brown RJ, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash YM, Vondran FW, Speerstra S, Awadh A, Mukhtarov F, ... ... Ploss A, et al. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology (Baltimore, Md.). PMID 26248546 DOI: 10.1002/hep.28111  1
2015 Ploss A, Walker C. Editorial overview: Progress and challenges in modeling human viral diseases in vivo. Current Opinion in Virology. 13: v-vii. PMID 26219570 DOI: 10.1016/j.coviro.2015.07.004  1
2015 Winer BY, Ploss A. Determinants of hepatitis B and delta virus host tropism. Current Opinion in Virology. 13: 109-16. PMID 26164658 DOI: 10.1016/j.coviro.2015.06.004  1
2015 Scull MA, Shi C, de Jong YP, Gerold G, Ries M, von Schaewen M, Donovan BM, Labitt RN, Horwitz JA, Gaska JM, Hrebikova G, Xiao JW, Flatley B, Fung C, Chiriboga L, ... ... Ploss A, et al. Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice. Hepatology (Baltimore, Md.). 62: 57-67. PMID 25820364 DOI: 10.1002/hep.27773  1
2015 Douam F, Ploss A. Proteomic approaches to analyzing hepatitis C virus biology. Proteomics. 15: 2051-65. PMID 25809442 DOI: 10.1002/pmic.201500009  1
2015 Stoddard MB, Li H, Wang S, Saeed M, Andrus L, Ding W, Jiang X, Learn GH, von Schaewen M, Wen J, Goepfert PA, Hahn BH, Ploss A, Rice CM, Shaw GM. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. Mbio. 6: e02518. PMID 25714714 DOI: 10.1128/mBio.02518-14  1
2015 Gardner MR, Kattenhorn LM, Kondur HR, von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC, Neale ES, Fellinger CH, Joshi VR, Fuchs SP, Martinez-Navio JM, ... ... Ploss A, et al. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature. 519: 87-91. PMID 25707797 DOI: 10.1038/nature14264  1
2015 Siu E, Ploss A. Modeling malaria in humanized mice: opportunities and challenges. Annals of the New York Academy of Sciences. 1342: 29-36. PMID 25678404 DOI: 10.1111/nyas.12618  1
2015 Gaska JM, Ploss A. Study of viral pathogenesis in humanized mice. Current Opinion in Virology. 11: 14-20. PMID 25618248 DOI: 10.1016/j.coviro.2015.01.002  1
2015 von Schaewen M, Ploss A. Novel Biomarkers Associated With the Outcome of Interferon-Based Hepatitis C Virus Therapy Cmgh Cellular and Molecular Gastroenterology and Hepatology. 1: 257-258. DOI: 10.1016/j.jcmgh.2015.03.005  1
2014 Ding Q, von Schaewen M, Ploss A. The impact of hepatitis C virus entry on viral tropism. Cell Host & Microbe. 16: 562-8. PMID 25525789 DOI: 10.1016/j.chom.2014.10.009  1
2014 Lacek K, Urbanowicz RA, Troise F, De Lorenzo C, Severino V, Di Maro A, Tarr AW, Ferrara F, Ploss A, Temperton N, Ball JK, Nicosia A, Cortese R, Pessi A. Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation. The Journal of Biological Chemistry. 289: 35015-28. PMID 25342747 DOI: 10.1074/jbc.M114.591826  1
2014 de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, ... ... Ploss A, et al. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Science Translational Medicine. 6: 254ra129. PMID 25232181 DOI: 10.1126/scitranslmed.3009512  1
2014 Ploss A. Mouse models for human infectious diseases. Journal of Immunological Methods. 410: 1-2. PMID 25017506 DOI: 10.1016/j.jim.2014.07.002  1
2014 Billerbeck E, Labitt RN, Vega K, Frias-Staheli N, Dorner M, Xiao JW, Rice CM, Ploss A. Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice. Immunology. 143: 202-18. PMID 24766459 DOI: 10.1111/imm.12304  1
2014 von Schaewen M, Ding Q, Ploss A. Visualizing hepatitis C virus infection in humanized mice. Journal of Immunological Methods. 410: 50-9. PMID 24642425 DOI: 10.1016/j.jim.2014.03.006  1
2014 Sheahan T, Imanaka N, Marukian S, Dorner M, Liu P, Ploss A, Rice CM. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. Cell Host & Microbe. 15: 190-202. PMID 24528865 DOI: 10.1016/j.chom.2014.01.007  1
2014 von Schaewen M, Ploss A. Murine models of hepatitis C: what can we look forward to? Antiviral Research. 104: 15-22. PMID 24462693 DOI: 10.1016/j.antiviral.2014.01.007  1
2014 Frias-Staheli N, Dorner M, Marukian S, Billerbeck E, Labitt RN, Rice CM, Ploss A. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. Journal of Virology. 88: 2205-18. PMID 24335303 DOI: 10.1128/JVI.03085-13  1
2014 Anggakusuma, Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J, Ott M, Meuleman P, Rice CM, Ploss A, Pietschmann T, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut. 63: 1137-49. PMID 23903236 DOI: 10.1136/gutjnl-2012-304299  1
2013 Horwitz JA, Halper-Stromberg A, Mouquet H, Gitlin AD, Tretiakova A, Eisenreich TR, Malbec M, Gravemann S, Billerbeck E, Dorner M, Büning H, Schwartz O, Knops E, Kaiser R, Seaman MS, ... ... Ploss A, et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 16538-43. PMID 24043801 DOI: 10.1073/pnas.1315295110  1
2013 Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T, Vogt A, Catanese MT, Satoh T, Kawai T, Akira S, Law M, Rice CM, Ploss A. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature. 501: 237-41. PMID 23903655 DOI: 10.1038/nature12427  1
2013 Billerbeck E, Horwitz JA, Labitt RN, Donovan BM, Vega K, Budell WC, Koo GC, Rice CM, Ploss A. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. Journal of Immunology (Baltimore, Md. : 1950). 191: 1753-64. PMID 23833235 DOI: 10.4049/jimmunol.1201518  1
2013 Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM, Ploss A. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology. 444: 1-11. PMID 23777661 DOI: 10.1016/j.virol.2013.05.036  1
2013 Gruell H, Bournazos S, Ravetch JV, Ploss A, Nussenzweig MC, Pietzsch J. Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model. Journal of Virology. 87: 8535-44. PMID 23720722 DOI: 10.1128/JVI.00868-13  1
2013 Guermonprez P, Helft J, Claser C, Deroubaix S, Karanje H, Gazumyan A, Darasse-Jèze G, Telerman SB, Breton G, Schreiber HA, Frias-Staheli N, Billerbeck E, Dorner M, Rice CM, Ploss A, et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nature Medicine. 19: 730-8. PMID 23685841 DOI: 10.1038/nm.3197  1
2013 Horwitz JA, Dorner M, Friling T, Donovan BM, Vogt A, Loureiro J, Oh T, Rice CM, Ploss A. Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology. 439: 23-33. PMID 23485372 DOI: 10.1016/j.virol.2013.01.019  1
2013 Billerbeck E, de Jong Y, Dorner M, de la Fuente C, Ploss A. Animal models for hepatitis C. Current Topics in Microbiology and Immunology. 369: 49-86. PMID 23463197 DOI: 10.1007/978-3-642-27340-7_3  1
2013 Shi C, Ploss A. Hepatitis C virus vaccines in the era of new direct-acting antivirals. Expert Review of Gastroenterology & Hepatology. 7: 171-85. PMID 23363265 DOI: 10.1586/egh.12.72  1
2013 Sandmann L, Ploss A. Barriers of hepatitis C virus interspecies transmission. Virology. 435: 70-80. PMID 23217617 DOI: 10.1016/j.virol.2012.09.044  1
2013 Dorner M, Rice CM, Ploss A. Study of hepatitis C virus entry in genetically humanized mice. Methods (San Diego, Calif.). 59: 249-57. PMID 22687621 DOI: 10.1016/j.ymeth.2012.05.010  1
2012 Klein F, Halper-Stromberg A, Horwitz JA, Gruell H, Scheid JF, Bournazos S, Mouquet H, Spatz LA, Diskin R, Abadir A, Zang T, Dorner M, Billerbeck E, Labitt RN, Gaebler C, ... ... Ploss A, et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature. 492: 118-22. PMID 23103874 DOI: 10.1038/nature11604  1
2012 Pietzsch J, Gruell H, Bournazos S, Donovan BM, Klein F, Diskin R, Seaman MS, Bjorkman PJ, Ravetch JV, Ploss A, Nussenzweig MC. A mouse model for HIV-1 entry. Proceedings of the National Academy of Sciences of the United States of America. 109: 15859-64. PMID 23019371 DOI: 10.1073/pnas.1213409109  1
2012 Vaughan AM, Mikolajczak SA, Wilson EM, Grompe M, Kaushansky A, Camargo N, Bial J, Ploss A, Kappe SH. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. The Journal of Clinical Investigation. 122: 3618-28. PMID 22996664 DOI: 10.1172/JCI62684  1
2012 Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A, Rice CM. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proceedings of the National Academy of Sciences of the United States of America. 109: 14610-5. PMID 22908290 DOI: 10.1073/pnas.1212379109  1
2012 Vaughan AM, Kappe SH, Ploss A, Mikolajczak SA. Development of humanized mouse models to study human malaria parasite infection. Future Microbiology. 7: 657-65. PMID 22568719 DOI: 10.2217/fmb.12.27  1
2012 Ploss A, Dubuisson J. New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets. Gut. 61: i25-35. PMID 22504917 DOI: 10.1136/gutjnl-2012-302048  1
2012 Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, Rice CM, Ploss A, Burton DR, Law M. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 109: 6205-10. PMID 22492964 DOI: 10.1073/pnas.1114927109  1
2012 Ploss A, Evans MJ. Hepatitis C virus host cell entry. Current Opinion in Virology. 2: 14-9. PMID 22440961 DOI: 10.1016/j.coviro.2011.12.007  1
2012 Meng X, Schoggins J, Rose L, Cao J, Ploss A, Rice CM, Xiang Y. C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. Journal of Virology. 86: 4538-47. PMID 22345458 DOI: 10.1128/JVI.06140-11  1
2012 Schwartz RE, Trehan K, Andrus L, Sheahan TP, Ploss A, Duncan SA, Rice CM, Bhatia SN. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 2544-8. PMID 22308485 DOI: 10.1073/pnas.1121400109  1
2012 Scull MA, Ploss A. Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines. Hepatology (Baltimore, Md.). 55: 645-8. PMID 22287293 DOI: 10.1002/hep.24716  1
2012 Ploss A. Reverse Genetic Tools to Study Hepatitis C Virus Reverse Genetics of Rna Viruses: Applications and Perspectives. 64-90. DOI: 10.1002/9781118405338.ch3  1
2011 Dorner M, Ploss A. Deconstructing hepatitis C virus infection in humanized mice. Annals of the New York Academy of Sciences. 1245: 59-62. PMID 22211981 DOI: 10.1111/j.1749-6632.2011.06317.x  1
2011 Andrus L, Marukian S, Jones CT, Catanese MT, Sheahan TP, Schoggins JW, Barry WT, Dustin LB, Trehan K, Ploss A, Bhatia SN, Rice CM. Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (Baltimore, Md.). 54: 1901-12. PMID 22144107 DOI: 10.1002/hep.24557  1
2011 Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, Ploss A, Rice CM, Dustin LB. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (Baltimore, Md.). 54: 1913-23. PMID 21800339 DOI: 10.1002/hep.24580  1
2011 Dorner M, Horwitz JA, Robbins JB, Barry WT, Feng Q, Mu K, Jones CT, Schoggins JW, Catanese MT, Burton DR, Law M, Rice CM, Ploss A. A genetically humanized mouse model for hepatitis C virus infection. Nature. 474: 208-11. PMID 21654804 DOI: 10.1038/nature10168  1
2011 Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. Blood. 117: 3076-86. PMID 21252091 DOI: 10.1182/blood-2010-08-301507  1
2011 Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, Barry W, Ploss A, Rice CM, Su L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 140: 1334-44. PMID 21237170 DOI: 10.1053/j.gastro.2011.01.001  1
2011 de Jong YP, Rice CM, Ploss A. Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice. Journal of Hepatology. 54: 848-50. PMID 21145816 DOI: 10.1016/j.jhep.2010.09.034  1
2010 Gerold G, Rice CM, Ploss A. Teaching new tricks to an old foe: murinizing hepatitis C virus. Hepatology (Baltimore, Md.). 52: 2233-6. PMID 21105113 DOI: 10.1002/hep.24045  1
2010 Sheahan T, Jones CT, Ploss A. Advances and challenges in studying hepatitis C virus in its native environment. Expert Review of Gastroenterology & Hepatology. 4: 541-50. PMID 20932139 DOI: 10.1586/egh.10.53  1
2010 Kohaar I, Ploss A, Korol E, Mu K, Schoggins JW, O'Brien TR, Rice CM, Prokunina-Olsson L. Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. Journal of Virology. 84: 6987-94. PMID 20463075 DOI: 10.1128/JVI.00196-10  1
2010 de Jong YP, Rice CM, Ploss A. New horizons for studying human hepatotropic infections. The Journal of Clinical Investigation. 120: 650-3. PMID 20179350 DOI: 10.1172/JCI42338  1
2010 Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, Gaysinskaya VA, Mu K, Ritola K, Rice CM, Bhatia SN. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proceedings of the National Academy of Sciences of the United States of America. 107: 3141-5. PMID 20133632 DOI: 10.1073/pnas.0915130107  1
2010 Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, Ploss A, Oh TS, Schoggins JW, MacDonald MR, Bhatia SN, Rice CM. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nature Biotechnology. 28: 167-71. PMID 20118917 DOI: 10.1038/nbt.1604  1
2009 Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, et al. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. Journal of Immunology (Baltimore, Md. : 1950). 183: 7919-30. PMID 19933869 DOI: 10.4049/jimmunol.0803903  1
2009 Ploss A, Rice CM. Towards a small animal model for hepatitis C. Embo Reports. 10: 1220-7. PMID 19834510 DOI: 10.1038/embor.2009.223  1
2009 Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host & Microbe. 6: 5-9. PMID 19616761 DOI: 10.1016/j.chom.2009.06.006  1
2009 Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, Münz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. The Journal of Experimental Medicine. 206: 1423-34. PMID 19487422 DOI: 10.1084/jem.20081720  1
2009 Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 457: 882-6. PMID 19182773 DOI: 10.1038/nature07684  1
2007 Biswas PS, Pedicord V, Ploss A, Menet E, Leiner I, Pamer EG. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. Journal of Immunology (Baltimore, Md. : 1950). 179: 4520-8. PMID 17878348  1
2006 Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, McKeating JA, Lanford RE, Feinstone SM, Major ME, Leroux-Roels G, Rice CM. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proceedings of the National Academy of Sciences of the United States of America. 103: 3805-9. PMID 16484368 DOI: 10.1073/pnas.0511218103  1
2005 Ploss A, Leiner I, Pamer EG. Distinct regulation of H2-M3-restricted memory T cell responses in lymph node and spleen. Journal of Immunology (Baltimore, Md. : 1950). 175: 5998-6005. PMID 16237094  1
2005 Ploss A, Tran A, Menet E, Leiner I, Pamer EG. Cross-recognition of N-formylmethionine peptides is a general characteristic of H2-M3-restricted CD8+ T cells. Infection and Immunity. 73: 4423-6. PMID 15972542 DOI: 10.1128/IAI.73.7.4423-4426.2005  1
2004 Dao T, Guo D, Ploss A, Stolzer A, Saylor C, Boursalian TE, Im JS, Sant'Angelo DB. Development of CD1d-restricted NKT cells in the mouse thymus. European Journal of Immunology. 34: 3542-52. PMID 15549774 DOI: 10.1002/eji.200425546  1
2004 Wong P, Lara-Tejero M, Ploss A, Leiner I, Pamer EG. Rapid development of T cell memory. Journal of Immunology (Baltimore, Md. : 1950). 172: 7239-45. PMID 15187098  1
2003 Ploss A, Lauvau G, Contos B, Kerksiek KM, Guirnalda PD, Leiner I, Lenz LL, Bevan MJ, Pamer EG. Promiscuity of MHC class Ib-restricted T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 171: 5948-55. PMID 14634106  1
2003 Kerksiek KM, Ploss A, Leiner I, Busch DH, Pamer EG. H2-M3-restricted memory T cells: persistence and activation without expansion. Journal of Immunology (Baltimore, Md. : 1950). 170: 1862-9. PMID 12574352  1
2001 Reuss FU, Heber R, Ploss A, Berdel B. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants Virology. 291: 91-100. PMID 11878879 DOI: 10.1006/viro.2001.1199  1
Show low-probability matches.